Madrigal Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$543.35(as of Jul 23, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Madrigal Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$543.35
Ticker SymbolMDGL
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees915
CountyUSA
Market Cap$12,395.9M
EBIDTA-312.0M
10-Day Moving Average541.73
P/E Ratio-50.98
20-Day Moving Average537.54
Forward P/E Ratio666.67
50-Day Moving Average516.04
Earnings per Share-13.50
200-Day Moving Average504.54
Profit Margin-30.32%
RSI54.66
Shares Outstanding23.1M
ATR21.09
52-Week High615.00
Volume160,513
52-Week Low286.44
Book Value543.5M
P/B Ratio29.03
Upper Keltner584.99
P/S Ratio13.93
Lower Keltner490.09
Next Earnings Date08/04/2026
Cash Surplus-106.1M
Next Ex-Dividend DateUnknown
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.